SEARCH

MENU

Current Edition

Avacta

Avacta appoints Dr Fiona McLaughlin as Chief Scientific Officer of its Therapeutics Division

Avacta Group plc (AIM: AVCT), a clinical-stage biopharmaceutical company developing innovative cancer therapies and powerful diagnostics based on its proprietary Affimer® and pre|CISION™ platforms, announces …

2 September 2021 Avacta Avacta Group plc

Continue Reading →

International Biopharmaceutical Industry

IBI – International Biopharmaceutical Industry was established to fill in the void for effective marketing and communication between all stakeholders in the Life sciences sector globally.

Bio Pharmaceutical Media © 2026, All Rights Reserved – Powered by Teksyte LTD